Mandelboim, O., Porgador, A. (2025). Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2507821122